IL17A and chronic obstructive pulmonary disease: Consistent with our results, a clinical study on the Treg/IL-17 ratio in COPD demonstrated an increase of both proinflammatory and anti-inflammatory responses in patients with COPD, dominated by proinflammatory responses, indicating an insufficient of Tregs [44].